Have your say about the EU Drug Strategy!

The European Commission has launched a public consultation to gather inputs by anyone affected by illicit drug use at the EU level

EU Drugs strategy evaluation questionnaire

A synopsis of the responses received will be included in the Staff Working Document that will be produced to summarise the findings of the evaluation

The EU Drug Strategy on Drugs 2013-2020 and the EU Action Plan on Drugs 2017-2020 are about to finish, as these both are supposed to last until 2020. It is therefore time to evaluate how both policy-guiding documents have been able to reach their objectives face the problems and prompt appropriate responses. The outcome of the consultation will be crucial to decide on if there will be even a future EU Drug Policy (which we truly hope!) and how it should be.

Opened until the 4th of February, the consultation targets a broad range of stakeholders, including public authorities and administrations at national, regional and local levels including customs and law enforcement, academia, anti-drugs and health related civil society and non-governmental organizations, chemical and medical industry representatives, practitioners involved in the drugs or health policy fields and private individuals. The consultation addresses all main policy areas of the Drugs Strategy, including drug demand and drug supply reduction and three cross-cutting themes, namely coordination, international cooperation and information, research and evaluation. Similar to the entire evaluation exercise, the consultation looks at the effectiveness, efficiency, relevance and coherence of the actions undertaken to cover the areas mentioned, as well as at the achieved EU added value.

The final results of the evaluation will be used by the European Commission, the European Parliament, and the Council and Member States in the future decision-making process regarding drug policy.

Links of interest